ArticleResearch square2025
Differences in "minty" flavor compound and synthetic cooling agent presence in US-marketed menthol-mint e-liquids and devices between 2019-2023.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Menthol and mint flavors consistently rank among the most popular flavor categories in electronic nicotine delivery systems (ENDS). While menthol/mint is often as a combined flavor category, different distinct "minty" flavors arise from a range of chemically distinct compounds to produce peppermint aroma (menthol, menthone, menthyl acetate, eucalyptol), spearmint aroma (L-carvone), and wintergreen aroma (methyl salicylate). In addition, the synthetic cooling agents WS-23 and WS-3 have gained popularity since 2019. This study analytically characterized menthol/mint ENDS products marketed in the United States in 2019 and 2023 for these compounds, alongside ancillary nicotine analysis. A total of 104 refill e-liquids purchased from online vendors in 2019 and 63 products purchased from online vendors in 2023 (including refill e-liquids, disposable devices, and pod-based products) were analyzed. In 2019 samples, menthol was prevalent (87/104 products; mean content 15.6 mg/g), whereas synthetic cooling agent use was rare (WS-23: 1/104; WS-3: 11/104). 2023 products showed decreased menthol concentrations (mean 8.3 mg/g), while synthetic coolant use became much more widespread (WS-23: 43/63; WS-3: 23/63). Synthetic coolant use prevalence was largely driven largely by disposable devices, all of which contained WS-23 at higher concentrations (mean 28.7 mg/g). Mint-, peppermint-, and spearmint-labeled products frequently contained overlapping flavorant profiles in both test samples, indicating limited reliability of label-based flavor categorization. Nicotine content closely matched labels for pod-based products but deviated substantially for disposables. Overall, results indicate a marked shift from menthol toward synthetic cooling agents in U.S. marketed ENDS products between 2019 and 2023, particularly in disposable products. This underscores the importance of analytical verification of menthol/mint ENDS products, but also suggests that regulatory efforts to limit the use of menthol due to its known cooling effect should not be limited to the compounds menthol, but should encompass all compounds that activate the relevant receptor TRPM8.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.